0 citations
Phase I study to the immunotherapy of metastatic malignant melanoma by a cancer vaccine consisting of autologous cancer cells transfected with the human IL-2 gene
Journal of Molecular Medicine1997Vol. 75(4), pp. 297–299
Citations Over Time
Georg Stingl, E.‐B. Bröcker, Roland Mertelsmann, K. Wolff, S. Schreiber, Eckhart Kämpgen, Achim Schneeberger, Jiri Trcka, U. Brennscheidt, Hendrik Veelken, Max L. Birnstiel, Kurt Zatloukal, Gerd Maass, Ernst Wagner, Michael Buschle, Ernst-Rudolf Kempe, Harald Weber, Thor Voigt
Related Papers
- → Analysis of BRAF Mutation in Primary and Metastatic Melanoma(2005)100 cited
- [Cancer Vaccine Focused on Neoantigens].(2019)
- Epidermotropic metastatic malignant melanoma.(1995)
- → The Role of BRAF/MEK Inhibition in Metastatic Malignant Melanoma – a Case Study(2016)1 cited
- Dendritic cells-based cancer vaccine : Cancer immunotherapy with tumor/dendritic cell fusions(2012)